Tổng số lượt xem trang

Thứ Bảy, 9 tháng 3, 2013

Lung US Detects Asymptomatic Lung Congestion


Technique can detect congestion before symptoms arise


Highlights

• Lung ultrasound can detect asymptomatic lung congestion in dialysis patients and can predict their risk of dying prematurely or experiencing heart attacks or other cardiac events.

• Treating asymptomatic lung congestion may help improve cardiovascular health and prevent cardiovascular deaths in dialysis patients.

• Lung congestion is highly prevalent and often asymptomatic among patients with kidney failure.


Washington, DC (February 28, 2013) — Asymptomatic lung congestion increases dialysis patients' risks of dying prematurely or experiencing heart attacks or other cardiac events, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology(JASN). The study also found that using lung ultrasound to detect this congestion helps identify patients at risk.

Lung congestion due to fluid accumulation is highly prevalent among kidney failure patients on dialysis, but it often doesn't cause any symptoms. To see whether such asymptomatic congestion affects dialysis patients' health, Carmine Zoccali, MD (Ospedali Riuniti, Reggio Calabria, Italy) and his colleagues measured the degree of lung congestion in 392 dialysis patients by using a very simple and inexpensive technique: lung ultrasound.

Among the major findings:

• Lung ultrasound revealed very severe congestion in 14% of patients and moderate-to-severe lung congestion in 45% of patients.

• Among those with moderate-to-severe lung congestion, 71% were asymptomatic.

• Compared with those having mild or no congestion, those with very severe congestion had a 4.2-fold increased risk of dying and a 3.2-fold increased risk of experiencing heart attacks or other cardiac events over a two-year follow-up period.

• Asymptomatic lung congestion detected by lung ultrasound was a better predictor of patients' risk of dying prematurely or experiencing cardiac events than symptoms of heart failure.

The findings indicate that assessing subclinical pulmonary edema can help determine dialysis patients' prognoses. "More importantly, our findings generate the hypothesis that targeting subclinical pulmonary congestion may improve cardiovascular health and reduce risk from cardiovascular death in the dialysis population, a population at an extremely high risk," said Dr. Zoccali. Fluid in the lungs may be reduced with longer and/or more frequent dialysis.

Investigators will soon start a clinical trial that will incorporate lung fluid measurements by ultrasound and will test whether dialysis intensification in patients with asymptomatic lung congestion can prevent premature death and reduce the risk of heart failure and cardiac events.

 
_________________________________________
 

Lung Ultrasound (LUS) examination

Methodology

LUS examination can be performed using any commercially available 2-D scanner, with any transducer (phased-array, linear-array, convex, microconvex). There is no need for a second harmonic or Doppler imaging mode. The examination can be performed with any type of echographic platform, from fully equipped machines to pocket size ones.[15] Patients can be in the near-supine, supine or sitting position, as clinically indicated.[16] All the chest can be easily scanned by ultrasound, just laying the probe along the intercostal spaces. However, some specific methods have been proposed: ultrasound scanning of the anterior and lateral chest may be obtained on the right and left hemithorax, from the second to the fourth (on the right side to the fifth) intercostal spaces, and from the parasternal to the axillary line, as previously described;[7,17] (figure 2). Other approaches have been proposed, for instance by Volpicelli et al.,[10] with evaluation of 8 scanning sites, 4 on the right and 4 on the left hemithorax. When assessing B-lines - the most informative LUS sign for the cardiologist - the sum of B-lines found on each scanning site yields a score, denoting the extent of extravascular fluid in the lung. In each scanning site, B-lines may be counted from zero to ten. Zero is defined as a complete absence of B-lines in the investigated area; the full white screen in a single scanning site is considered, when using a cardiac probe, as corresponding to 10 B-lines (figure 3). Sometimes B-lines can be easily enumerated, especially if they are a few; whereas, when they are more numerous, it is less easy to clearly enumerate them, since they tend to be confluent. In this situation, in order to obtain a semiquantification of the sign, one can consider the percentage of the scanning site occupied by B-lines (i.e. the percentage of white screen compared to black screen) and then divide it by ten (figure 3). For clinical purposes, B-lines may be categorized from mild to severe degree, similar to what is done for most echocardiographic parameters,[16] (Table 1). B-lines have a very satisfactory intraobserver and interobserver variability, around 5% and 7%, respectively.[7]

Limitations


LUS limitations are essentially patient dependent. Obese patients are frequently difficult to examine because of the thickness of their ribcage and soft tissues. The presence of subcutaneous emphysema or large thoracic dressings alters or precludes the propagation of ultrasound beams to the lung periphery.

The main limitation of B-lines is the lack of specificity. As already mentioned, they are a sign of interstitial syndrome, therefore they are a very sensitive but not specific sign of cardiogenic pulmonary edema. How to distinguish the different etiologies of B-lines has been discussed. However, it must be always reminded that all instrumental data should be evaluated within the clinical context and integrated with patient's history. No single test alone allows to establish the diagnosis.
 
From
Lung Ultrasound: A New Tool for the Cardiologist - Medscape

 


NEW MATERIAL IMPROVING ULTRASOUND TECHNOLOGY



 
 
Ultrasound Imaging Technology Enhanced with Golden Nanorods Encased in Polymer
 
Ultrasound technology could soon undergo a significant enhancement that would enable it to generate high quality, high-resolution images, due to the development of a new key material.
The material, which converts ultrasound waves into optical signals that can be used to produce an image, is the result of a collaborative effort by Prof. Vladislav Yakovlev, a professor in the department of biomedical engineering at Texas A&M University (College Station, USA; www.tamu.edu), and researchers from King’s College London (UK;www.kcl.ac.uk), The Queen’s University Belfast (Ireland; www.qub.ac.uk), and the University of Massachusetts Lowell (USA; www.uml.edu). Their study findings appear in the March 1, 2013, issue of the journal Advanced Materials.
The modified substance, known as a “metamaterial,” offers substantial advantages over traditional ultrasound technology, which generates images by transforming ultrasound waves into electrical signals, Prof. Yakovlev explained.
Although that technology has advanced throughout the years similar to the improvement in sonogram images, it is still mostly constrained by bandwidth and sensitivity limitations, he noted.These limitations, he added, have been the chief obstacle when it comes to producing high-quality images that can serve as powerful diagnostic tools. The metamaterial developed by Prof.Yakovlev and his colleagues is not subject to those limitations, primarily because it converts ultrasound waves into optical signals rather than electrical ones. The optical processing of the signal does not limit the bandwidth or sensitivity of the transducer (converter), which is vital for generating very detailed images, Prof. Yakovlev said. “A high bandwidth allows you to sample the change of distance of the acoustic waves with a high precision,” Prof. Yakovlev noted. “This translates into an image that shows greater detail. Greater sensitivity enables you to see deeper in tissue, suggesting we have the potential to generate images that might have previously not been possible with conventional ultrasound technology.”
Meaning, this new material may enable ultrasound devices to see what they have not yet been able to see. That advancement could significantly boost a technology that is utilized in a range of biomedical applications. In addition to being used for visualizing fetuses during regular and emergency care, ultrasound is used for diagnostic purposes in events of trauma and even as a means of breaking up tissue and accelerating the effects of drugs therapies. Whereas this research is not yet ready for incorporation into ultrasound technology, it has effectively shown how conventional technology can be substantially enhanced by using the newly engineering material created by his team, Prof. Yakovlev reported.
The substance, he noted, is comprised of golden nanorods embedded in a polymer called a polypyrrole. An optical signal is sent into this compound where it interacts with and is changed by incoming ultrasound waves before passing through the material. A detection device would then read the changed optical signal, analyzing the changes in its optical characteristics to process a higher resolution image, he clarified.
“We developed a material that would enable optical signal processing of ultrasound,” Prof. Yakovlev concluded. “Nothing like this material exists in nature so we engineered a material that would provide the properties we needed. It has greater sensitivity and broader bandwidth. We can go from 0–150 MHz without sacrificing the sensitivity. Current technology typically experiences a substantial decline in sensitivity around 50 MHz.
This metamaterial can efficiently convert an acoustic wave into an optical signal without restricting the bandwidth of the transducer, and its potential biomedical applications represent the first practical implementation of this metamaterial.”